Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 100 uM SGLT2 inhibitor phloretin and measured after 60 mins post drug dose by HPLC analysis
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 100 uM SGLT1 inhibitor phloridzin dihydrate and measured after 60 mins post drug dose by HPLC analysis
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 10 uM SGLT1 inhibitor phloridzin dihydrate and measured after 60 mins post drug dose by HPLC analysis
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 100 uM SGLT2 inhibitor phloretin and measured after 30 mins post drug dose by HPLC analysis
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 100 uM SGLT1 inhibitor phloridzin dihydrate and measured after 30 mins post drug dose by HPLC analysis
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 10 uM SGLT1 inhibitor phloridzin dihydrate and measured after 30 mins post drug dose by HPLC analysis
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 100 uM SGLT2 inhibitor phloretin and measured after 15 mins post drug dose by HPLC analysis
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 100 uM SGLT1 inhibitor phloridzin dihydrate and measured after 15 mins post drug dose by HPLC analysis
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM added 10 mins after 10 uM SGLT1 inhibitor phloridzin dihydrate and measured after 15 mins post drug dose by HPLC analysis
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM after 60 mins by HPLC analysis
Assay data:4 Active, 5 Tested
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM after 30 mins by HPLC analysis
Assay data:5 Active, 5 Tested
Intestinal permeability in ex vivo Wistar rat everted gut sac model assessed as GLUT2-mediated drug permeation by measuring drug level permeated through intestinal membrane at 100 uM after 15 mins by HPLC analysis
Assay data:5 Active, 1 Activity ≤ 1 µM, 5 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on